It has been shown that CD14+/DR− MDSCs isolated from MDS patients are capable of suppressing the proliferation of both allogeneic and autologous CD4 cells in vitro, although they were not directly compared with the suppressive capacity of healthy donor-derived MDSCs [80]. The gene discussed is CD14; the disease is myelodysplastic syndrome.